array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Becton, Dickinson and Company"
["slug"]=>
string(37) "4601d-us-becton-dickinson-and-company"
["logo"]=>
NULL
["description"]=>
NULL
["address_street"]=>
string(11) "1 Becton Dr"
["address_place"]=>
string(14) "Franklin Lakes"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1897-02-28"
["website_domain"]=>
string(6) "bd.com"
["website_url"]=>
string(18) "https://www.bd.com"
["industry_codes"]=>
array(2) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
[1]=>
string(60) "Orthopedic, Prosthetic, and Surgical Appliances and Supplies"
}
["employee_count"]=>
int(1500)
["article_count"]=>
int(417)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(61) "Becton, Dickinson and Company (BDX) Declined on 2024 Guidance"
["snippet_en"]=>
string(293) "Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the fourth quarter, equity markets ended the year on a high note, with the S&P 500 achieving an 11.7% increase."
["url"]=>
string(83) "https://finance.yahoo.com/news/becton-dickinson-company-bdx-declined-052333036.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4c3b1a59-d4f1-4399-922d-fdc2e1f3d030"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-02-05"
["categories"]=>
array(7) {
[0]=>
string(12) "Stock Market"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(9) "Investors"
[3]=>
string(18) "General Investment"
[4]=>
string(22) "Sustainable Investment"
[5]=>
string(19) "Investment Requests"
[6]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(50) "BD reports 2.6% revenue increase in Q1 fiscal 2024"
["snippet_en"]=>
string(139) "Becton, Dickinson and Company (BD) reported a revenue of $4.7bn for Q1 of fiscal 2024, marking a 2.6% increase from the last year's $4.5bn."
["url"]=>
string(69) "https://www.medicaldevice-network.com/news/bd-revenue-q1-fiscal-2024/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9cb0737a-90b3-467c-bcc6-e3b343cb28d0"
["source"]=>
string(25) "medicaldevice-network.com"
["publication_date"]=>
string(10) "2024-02-02"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(74) "Becton, Dickinson and Company (NYSE:BDX) Updates FY 2024 Earnings Guidance"
["snippet_en"]=>
string(192) "Becton, Dickinson and Company (NYSE:BDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 12.700-13.000 for the period, compared to the consensus estimate of 12.840."
["url"]=>
string(80) "https://www.marketbeat.com/instant-alerts/nyse-bdx-earnings-guidance-2024-01-30/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fcc5ea78-060d-4200-8c03-1164f98b410d"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2024-01-30"
["categories"]=>
array(5) {
[0]=>
string(12) "Stock Market"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(13) "Credit Rating"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(24) "Quarterly/Annual Figures"
}
}
[3]=>
array(7) {
["title_en"]=>
string(82) "Becton, Dickinson and Company (BDX) Set to Announce Quarterly Earnings on Thursday"
["snippet_en"]=>
string(242) "Becton, Dickinson and Company (NYSE:BDX – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, February 1st. Analysts expect the company to announce earnings of $2.39 per share for the quarter."
["url"]=>
string(124) "https://www.defenseworld.net/2024/01/25/becton-dickinson-and-company-bdx-set-to-announce-quarterly-earnings-on-thursday.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4bfeb520-8e49-46fe-8bd5-9e4fc6c1a9a3"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-01-25"
["categories"]=>
array(5) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(24) "Quarterly/Annual Figures"
}
}
[4]=>
array(7) {
["title_en"]=>
string(67) "Becton, Dickinson and Company Q4 Profit Decreases, misses estimates"
["snippet_en"]=>
string(149) "(RTTNews) - Becton, Dickinson and Company (BDX) announced earnings for fourth quarter that decreased from last year and missed the Street estimates."
["url"]=>
string(97) "https://www.nasdaq.com/articles/becton-dickinson-and-company-q4-profit-decreases-misses-estimates"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-11-09"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[5]=>
array(7) {
["title_en"]=>
string(66) "Becton, Dickinson and Company Q3 Profit Increases, beats estimates"
["snippet_en"]=>
string(197) "WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) reported a profit for its third quarter that increased from the same period last year and beat the Street estimates.The company's earnings"
["url"]=>
string(134) "https://www.finanznachrichten.de/nachrichten-2023-08/59750899-becton-dickinson-and-company-q3-profit-increases-beats-estimates-020.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3d1199ad-c93b-459b-adb5-1240fc221577"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-08-03"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[6]=>
array(7) {
["title_en"]=>
string(57) "BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised"
["snippet_en"]=>
string(230) "Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $2.86 for the second quarter of fiscal 2023, up 2.9% year over year. The figure surpassed the Zacks Consensus Estimate by 4%."
["url"]=>
string(86) "https://www.nasdaq.com/articles/bd-bdx-q2-earnings-surpass-estimates-fy23-view-revised"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-05-04"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[7]=>
array(7) {
["title_en"]=>
string(66) "Becton, Dickinson and Company Q2 Profit Increases, beats estimates"
["snippet_en"]=>
string(150) "(RTTNews) - Becton, Dickinson and Company (BDX) reported earnings for its second quarter that increased from last year and beat the Street estimates."
["url"]=>
string(98) "https://www.nasdaq.com/articles/becton-dickinson-and-company-q2-profit-increases-beats-estimates-0"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-05-04"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[8]=>
array(7) {
["title_en"]=>
string(65) "Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results"
["snippet_en"]=>
string(162) "PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care..."
["url"]=>
string(136) "https://www.globenewswire.com/news-release/2023/02/14/2607411/0/en/Embecta-Corp-Reports-First-Quarter-Fiscal-2023-Financial-Results.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/dcf8f3e7-2359-4a92-a388-43b84e57c8c8"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2023-02-14"
["categories"]=>
array(1) {
[0]=>
string(24) "Quarterly/Annual Figures"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(44)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(26)
}
[2]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[3]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(20)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(20)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(15)
}
[8]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(13)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(12)
}
[12]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(8)
}
[16]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(14) "Product Recall"
["count"]=>
int(6)
}
[20]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(6)
}
[21]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[22]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(5)
}
[23]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(5)
}
[24]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[25]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(4)
}
[26]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(4)
}
[27]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(4)
}
[28]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(4)
}
[29]=>
array(2) {
["name"]=>
string(19) "Green & Responsible"
["count"]=>
int(4)
}
}
}
4601d-us-becton-dickinson-and-company
Becton, Dickinson and Company
Website
https://www.bd.com
Category
Surgical and Medical Instruments and Apparatus
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Articles
2024-02-05 (yahoo.com)
Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the fourth quarter, equity markets ended the year on a high note, with the S&P 500 achieving an 11.7% increase.
Read more
2024-02-02 (medicaldevice-network.com)
Becton, Dickinson and Company (BD) reported a revenue of $4.7bn for Q1 of fiscal 2024, marking a 2.6% increase from the last year's $4.5bn.
Read more
2024-01-30 (marketbeat.com)
Becton, Dickinson and Company (NYSE:BDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 12.700-13.000 for the period, compared to the consensus estimate of 12.840.
Read more
2024-01-25 (defenseworld.net)
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, February 1st. Analysts expect the company to announce earnings of $2.39 per share for the quarter.
Read more
2023-11-09 (nasdaq.com)
(RTTNews) - Becton, Dickinson and Company (BDX) announced earnings for fourth quarter that decreased from last year and missed the Street estimates.
Read more
2023-08-03 (finanznachrichten.de)
WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) reported a profit for its third quarter that increased from the same period last year and beat the Street estimates.The company's earnings
Read more
2023-05-04 (nasdaq.com)
Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $2.86 for the second quarter of fiscal 2023, up 2.9% year over year. The figure surpassed the Zacks Consensus Estimate by 4%.
Read more
2023-05-04 (nasdaq.com)
(RTTNews) - Becton, Dickinson and Company (BDX) reported earnings for its second quarter that increased from last year and beat the Street estimates.
Read more
2023-02-14 (globenewswire.com)
PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care...
Read more
Newsletter subscription
Notice: JavaScript is required for this content.